Approval of Abilify (aripiprazole) for the treatment of acute ...
619596
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the US Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
118432
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Alimta, for the treatment of advanced non-small cell lung cancer in previously treated patients.
166855
Johnson & Johnson won clearance to promote its schizophrenia drug Risperdal for treating irritability in children and adolescents with autism, U.S. health officials said on Friday.
567241
Drug company Eli Lilly  has  encouraged primary care physicians to use Zyprexa, a powerful  drug for schizophrenia and bipolar disorder, in patients who  did not have either condition, the New York Times reported on  its Web site on Monday, citing internal Lilly marketing  materials.
641614
NEW YORK  - Within 2 years after the October 2003 FDA public health advisory about the risk of suicide in children taking a type of antidepressant called selective serotonin reuptake inhibitors (SSRIs), significant reductions in rates of diagnosis and antidepressant treatment of childhood depression occurred, researchers report.
127205
NEW YORK - Pfizer announced that it has received clearance from the US Food and Drug Administration to market its antipsychotic Geodon for acute bipolar mania, when patients suffer from unnatural highs that can last for a week or more.
287117
Drug company Eli Lilly  has encouraged primary care physicians to use Zyprexa, a powerful drug for schizophrenia and bipolar disorder, in patients who did not have either condition, the New York Times reported on its Web site on Monday, citing internal Lilly marketing materials.
758408
WASHINGTON -- The Food and Drug Administration on Wednesday approved a widely used adult psychiatric drug for the treatment of schizophrenia and bipolar disorder in children and adolescents.
603982
The US Food and Drug Administration has approved Tysabri (natalizumab) as a new treatment for multiple sclerosis. The incurable nervous system disease affects about 350,000 Americans.
63904
A new study finds that an older antipsychotic drug is cheaper and equally effective for some patients with schizophrenia, sending makers of newer drugs scrambling to defend their products on Friday.
128120
Some local doctors are not thrilled with a national study on anti-depression. The Food and Drug Administration says drugs, like Prozac and Paxil, can increase the chances of suicide among children and teens.
135618
(National-NBC) Nov. 24, 2004 - The Food and Drug Administration has approved the first drug that specifically targets Multiple Sclerosis.
287736
TORONTO - A new but potentially costly treatment for multiple sclerosis has received fast-track approval from the US Food and Drug Administration.
64073
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohnâs disease.
438501
Here's what a newly approved drug looks like.
254226
The antidepressant citalopram (Celexa) appears to be a safe and effective treatment for anxiety disorders in older patients, a small trial suggests.